Physician profile
Bryan Veynovich
NPI 1104887413
$859.66
in general payments reported to CMS, 2019-2025
18 companies · $20.06 in 2025
The $20.06 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $678 · 2020: $135 · 2024: $26.26 · 2025: $20.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $46.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $46.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $224.50 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $139.52 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $74.77 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $70.47 | 2019 | |
| Fisher & Paykel Healthcare INC | $46.32 | 2024-2025 | Fisher & Paykel Healthcare |
| Mylan Specialty L.P. | $46.07 | 2019 | |
| Circassia INC. | $45.30 | 2019 | |
| Grifols USA, LLC | $45.18 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $25.48 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $19.45 | 2019 | |
| Csl Behring | $18.17 | 2019 | |
| Genzyme Corporation | $17.56 | 2019 | |
| Merck Sharp & Dohme LLC | $16.16 | 2019 | |
| United Therapeutics Corporation | $16.11 | 2019 | |
| Astellas Pharma US INC | $15.12 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $14.61 | 2019 | |
| Genentech USA, INC. | $13.30 | 2019 | |
| Resmed Corp | $11.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Veynovich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.